Ernexa Therapeutics, Inc. (ERNA)
0.1891
-0.01
(-6.43%)
USD |
NASDAQ |
Apr 15, 16:00
0.187
0.00 (0.00%)
Pre-Market: 08:05
Ernexa Therapeutics Cash from Investing (Quarterly) : -0.015M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -2.839M |
| Quince Therapeutics, Inc. | 8.071M |
| Recursion Pharmaceuticals, Inc. | -1.244M |
| Tango Therapeutics, Inc. | -135.72M |
| Aprea Therapeutics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.148M |
| Free Cash Flow | -7.054M |
| Free Cash Flow Per Share (Quarterly) | -0.1481 |
| Free Cash Flow to Equity (Quarterly) | -1.101M |
| Free Cash Flow to Firm (Quarterly) | -1.163M |
| Free Cash Flow Yield | -200.0% |